News | Proton Therapy | September 21, 2015

Facility to begin treating patients at the end of 2018

September 21, 2015 — IBA (Ion Beam Applications SA) announced that it has signed a contract with the company INVAP for the installation of a proton therapy center at the Instituto de Oncologia Angel Roffo hospital in Buenos Aires, Argentina.

IBA will equip the new center with its ProteusPlus system, including one gantry treatment room with next-generation pencil beam scanning capability and one research and development room. The contract will also include an operation and maintenance agreement. The equipment and services that will be supplied by IBA are worth between EUR 35 and 40 million to IBA.

This first proton therapy center to be installed in Latin America is part of the implementation of the Nuclear Medicine National Plan of the Argentine Ministry of Federal Planning, Public Investment and Services, together with the Ministry of Health and the National Atomic Energy Commission (CNEA). The Nuclear Medicine National Plan is a unique government plan of investment in infrastructure and equipment designed to ensure free access to the highest standards in prevention, treatment, research and training in nuclear medicine and oncology. It is expected that the center will treat its first patient at the end of 2018.

The Argentine Minister of Federal Planning, Public Investment and Services, Julio De Vido, commented: "Bringing an innovative new cancer center closer to the people has the objective to give better chances to fight this severe disease. Argentina is the first country in Latin America to have access to this unique medical technology which will be beneficial for the health of patients in the country.”

For more information: www.iba-worldwide.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now